Ketone Ester Treatment Improves Cardiac Function and Reduces Pathologic Remodeling in Preclinical Models of Heart Failure
Salva R. Yurista(University Medical Center Groningen), B. Daan Westenbrink(University Medical Center Groningen), Daniel P. Kelly(Washington University in St. Louis), Rudolf A. de Boer(Uppsala University), Herman H.W. Silljé(University Medical Center Groningen), Kirsten T. Nijholt(University Medical Center Groningen), Dirk J. van Veldhuisen(University Medical Center Groningen), Kendra S. McDaid(University of Pennsylvania), John C. Newman(Buck Institute for Research on Aging), Teresa C. Leone(Cardiovascular Institute of the South), Swapnil V. Shewale(University of Pennsylvania), Timothy Matsuura(University of Minnesota System), Eric Verdin(Buck Institute for Research on Aging)
Cited by 145
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
|European Heart Journal|2015|3.9k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
|European Journal of Heart Failure|2008|3.5k